anagrelide (Torrent Pharmaceuticals Limited)
Welcome to the PulseAid listing for the anagrelide drug offered from Torrent Pharmaceuticals Limited. This Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Torrent Pharmaceuticals Limited |
| NON-PROPRIETARY NAME: | anagrelide |
| SUBSTANCE NAME: | ANAGRELIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-30 |
| END MARKETING DATE: | 0000-00-00 |
anagrelide HUMAN PRESCRIPTION DRUG Details:
| Item Description | anagrelide from Torrent Pharmaceuticals Limited |
| LABELER NAME: | Torrent Pharmaceuticals Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2017-06-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13668-453_da9106e7-80de-4af7-8d38-c1ac79b6c1ee |
| PRODUCT NDC: | 13668-453 |
| APPLICATION NUMBER: | ANDA209151 |
Other ANAGRELIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
